Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects

Destruction of the alveolar bone in the jaws can occur due to periodontitis, trauma or following tumor resection. Common reconstructive therapy can include the use of bone grafts with limited predictability and efficacy. Romosozumab, approved by the FDA in 2019, is a humanized sclerostin-neutralizin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Yao, Yao, Kauffmann, Frederic, Maekawa, Shogo, Sarment, Lea V., Sugai, James V., Schmiedeler, Caroline A., Doherty, Edward J., Holdsworth, Gill, Kostenuik, Paul J., Giannobile, William V.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7530715/
https://ncbi.nlm.nih.gov/pubmed/33004873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-73026-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados